The brachial plexus injury market has seen considerable growth due to a variety of factors.
• The brachial plexus injury market has grown rapidly in recent years. It will increase from $5.73 billion in 2024 to $6.47 billion in 2025 at a CAGR of 12.8%.
This growth is attributed to the rising incidence of trauma from road accidents and sports injuries, increased awareness and early diagnosis, improvements in healthcare accessibility, a growing elderly population, expanding healthcare insurance coverage for complex surgeries, and regulatory approvals for new treatments.
The brachial plexus injury market is expected to maintain its strong growth trajectory in upcoming years.
• The brachial plexus injury market is expected to grow rapidly, reaching $10.37 billion by 2029 at a CAGR of 12.5%.
Growth is attributed to the aging population, advanced imaging techniques, minimally invasive surgery, increased R&D in biologics, healthcare expenditure growth, and collaborations. Trends include robotic-assisted surgeries, telemedicine for post-op care, bioresorbable nerve conduits, AI for patient-specific treatment, and personalized rehab programs.
The rise in road accidents is expected to propel the growth of the brachial plexus injury market. Road accidents, often caused by speeding and driver negligence, can lead to serious injuries, including brachial plexus injuries. These injuries require treatments such as nerve grafting and rehabilitation therapies. According to a January 2024 report by The Road Safety Authority, road deaths in Ireland increased by 19% in 2023 compared to 2022, contributing to the growth of the brachial plexus injury market.
The brachial plexus injury market covered in this report is segmented –
1) By Type: Avulsion, Rupture, Neurapraxia, Axonotmesis, Neurotmesis, Neuroma
2) By Diagnosis: Clinical Examination, Electrodiagnostic, Imaging Studies
3) By Treatment: Therapy, Surgery
4) By Indication: Trauma, Inflammation, Contact Sports, Tumors, Radiation Treatment, Other Indications
Subsegments:
1) By Avulsion: Total Avulsion (Complete Disruption), Partial Avulsion (Partial Disruption)
2) By Rupture: Upper Trunk Rupture, Lower Trunk Rupture, Upper And Lower Trunk Rupture
3) By Neurapraxia: Mild Neurapraxia (Temporary Loss Of Function), Moderate Neurapraxia (Temporary Nerve Block)
4) By Axonotmesis: Partial Axonotmesis (Axon Damage With Preserved Nerve Structure), Severe Axonotmesis (Complete Axon Damage)
5) By Neurotmesis: Complete Neurotmesis (Complete Nerve Disruption), Partial Neurotmesis (Partial Nerve Disruption)
6) By Neuroma: Traumatic Neuroma (Nerve Regeneration Abnormalities), Post-Surgical Neuroma (Nerve Scarring After Surgery)
Companies in the brachial plexus injury market are developing advanced nerve repair products to improve recovery and patient mobility. These devices promote the healing and regeneration of damaged nerves. For example, in March 2022, Integra LifeSciences Holding Corporation, a US-based medical technology company, launched the NeuraGen 3D Nerve Guide Matrix, a resorbable implant that optimizes conditions for peripheral nerve recovery.
Major companies operating in the brachial plexus injury market are:
• Cardinal Health Inc.
• Johnson And Johnson
• Medtronic plc
• Fujifilm Holdings Corporation
• Becton Dickinson and Company
• Stryker Corporation
• Baxter International Inc.
• Boston Scientific Corporation
• B. Braun Melsungen AG
• Zimmer Biomet Holdings Inc.
• Olympus Corporation
• Terumo Corporation
• Smith And Nephew plc
• Arthrex Inc.
• Teleflex Incorporated
• Karl Storz SE And Co. KG
• Cook Medical LLC
• Integra LifeSciences Holdings Corporation
• CONMED Corporation
• DJO Global Inc.
• LivaNova PLC
• MicroPort Scientific Corporation
• Wright Medical Group N.V.
• AngioDynamics Inc.
• Pentax Medical
North America was the largest region in the brachial plexus injury market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the brachial plexus injury market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.